Targeted delivery across the blood–brain barrier
✍ Scribed by Gaillard, Pieter J; Visser, Corine C; de Boer, Albertus G
- Book ID
- 120648211
- Publisher
- Informa plc
- Year
- 2005
- Tongue
- English
- Weight
- 483 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1742-5247
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Glial‐derived neurotrophic factor (GDNF) is a neurotrophin that could be developed as a neurotherapeutic for Parkinson's disease, stroke, and motor neuron disease. However, GDNF does not cross the blood–brain barrier (BBB). Human GDNF was re‐engineered by fusion of the mature GDNF prote
## Abstract Mucopolysaccharidosis Type I, Hurler's Syndrome, is a lysosomal storage disorder that affects the brain. The missing enzyme, α‐L‐iduronidase (IDUA), does not cross the blood‐brain barrier (BBB). To enable BBB transport of the enzyme, human IDUA was fused to the carboxyl terminus of the